1 415

Cited 45 times in

Markedly Enhanced Cytolysis by E1B-19kD-Deleted Oncolytic Adenovirus in Combination with Cisplatin

 A-Rum Yoon  ;  Joo-Hang Kim  ;  Young-Sook Lee  ;  Hoguen Kim  ;  Ji-Young Yoo  ;  Joo-Hyuk Sohn  ;  Byeong-Woo Park  ;  Chae-Ok Yun 
 HUMAN GENE THERAPY, Vol.17(4) : 379-390, 2006 
Journal Title
Issue Date
Adenoviridae*/genetics ; Adenovirus E1B Proteins/genetics* ; Animals ; Antineoplastic Agents/administration & dosage* ; Cell Death ; Cell Line, Tumor ; Cisplatin/administration & dosage* ; Combined Modality Therapy ; Dose-Response Relationship, Drug ; Gene Deletion ; Humans ; Mice ; Mice, Nude ; Neoplasms/pathology ; Neoplasms/therapy ; Oncolytic Virotherapy* ; Oncolytic Viruses* ; Transplantation
Oncolytic adenoviruses are currently being developed as novel antitumor therapeutics. To enhance their therapeutic potential, adenoviruses are being administered in combination with standard chemotherapy. Adenoviral vectors used in these clinical trials, however, can be destructive as they encode intact E1B 19-kDa protein, which can block the apoptotic pathway induced by a variety of chemotherapeutic agents. Previously, we have shown that oncolytic adenovirus Ad-ΔE1B19/55, deleted for sequence encoding E1B 19-kDa and E1B 55-kDa proteins, exhibits marked enhancement in cytolytic and apoptotic activity [Kim, J., Cho, J.Y., Kim, J.H., Jung, K.C., and Yun, C.O. (2002). Cancer Gene Ther. 9, 725–736]. In the current study, we assess the therapeutic value of Ad- ΔE1B55 and Ad-ΔE1B19/55 in combination with cisplatin. A marked increase in cytotoxicity was observed for both Ad-ΔE1B55 and Ad-ΔE1B19/55 when combined with cisplatin. Relative to each other in all cell lines examined, the combination of the double-deleted adenovirus, Ad-ΔE1B19/55, plus cisplatin exhibited a greater cell-killing effect than did the single-deleted adenovirus, Ad-ΔE1B55, plus cisplatin. Propidium iodide staining and TUNEL analysis also revealed that the combination of cisplatin with Ad-ΔE1B19/55 caused greater induction of apoptosis than that with Ad-ΔE1B55. Similarly, in vivo, the combination of Ad-ΔE1B55 or Ad-ΔE1B19/55 with cisplatin also induced greater antitumor effect in a human cervical xenograft model. TUNEL staining showed that the apoptotic level was significantly higher in tumor tissue treated with Ad-ΔE1B19/55 plus cisplatin than with any other treatment. In addition, viral presence was confirmed by immunohistological staining, with increased numbers of adenoviral particles detected in wider areas of tumors treated with Ad-ΔE1B19/55 oncolytic adenovirus plus cisplatin. Taken together, these findings demonstrate that cisplatin in combination with E1B- 19kD-deleted oncolytic adenovirus may enhance therapeutic efficacy (via active induction of apoptosis), eliciting a greater efficacy profile than that with E1B-19kD-expressing oncolytic adenovirus.
Full Text
Appears in Collections:
1. College of Medicine (의과대학) > Research Institute (부설연구소) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Joo Hang(김주항)
Kim, Hogeun(김호근)
Park, Byeong Woo(박병우) ORCID logo https://orcid.org/0000-0003-1353-2607
Sohn, Joo Hyuk(손주혁) ORCID logo https://orcid.org/0000-0002-2303-2764
Yun, Chae Ok(윤채옥)
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.